Shares U.S. Pharmaceuticals ETF offers growth and dividends from top holdings like LLY, JNJ, MRK with strong earnings and ...
1dOpinion
Why Is Merck Stock Surging?
Merck (MRK)’s stock surged by 41%, driven not significantly by revenue but rather by increased profits and heightened ...
Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...
Merck Animal Health plans a $985 million expansion of its manufacturing facility in De Soto. Merck Animal Health's expansion ...
A Manhattan federal jury found Merck & Co. discriminated against a director of compliance and risk management by terminating ...
The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...
Merck Foundation underscores their long-term partnership with Angola First Lady to train healthcare providers and support ...
De Soto planners have delayed approval of Merck Animal Health's site plan to review fire lane and traffic flow details for the animal vaccine maker's expansion.
With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...
Kelun Biotech's sac-TMT plus Merck's Keytruda shows significant progress in late-stage lung cancer trial. Read more here.
Shares of Merck and UnitedHealth are seeing strong returns Tuesday morning, sending the Dow Jones Industrial Average into positive territory.
Investing.com -- Merck shares received an upgrade at Wells Fargo, with analyst Mohit Bansa lifting the stock to Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback